▽tositumomab - PubMed - NCBI ●01/09 16:44 Tositumomab.[No authors listed] [No authors listed] 2020 Apr 15. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012–. 2020 Apr 15. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and
▽NCCN Clinical Practice Guidelines in Oncology ●01/09 16:31 Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic Genetic/Familial High-Risk Assessment: Breast, Ovarian, Pancreatic, and Prostate Genetic/Familial High-Risk Assessment: Colorectal, Endometrial, and GastricLung Cancer Screening Prostate Cancer Early DetectionVersion: 3.2024Version: 3.2024Version: 2.2025
▽Brentuximab vedotin - PubMed - NCBI ●01/09 15:34 2025 81,596 resultsBrentuximab vedotin in T-cell lymphoma.Van Der Weyden C, Dickinson M, Whisstock J, Prince HM. Van Der Weyden C, et al. Expert Rev Hematol. 2019 Jan;12(1):5-19. doi: 10.1080/17474086.2019.1558399. Epub 2018 Dec 18. Expert Rev Hematol. 2019. PMID: 30526166 Review.Brentuximab vedotin is an antibody-drug conjugate, which combines a CD30 monoclonal antibody with the microtubule-d
